How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 12, Pages e83193
Publisher
Public Library of Science (PLoS)
Online
2013-12-31
DOI
10.1371/journal.pone.0083193
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Understanding the Potential Impact of a Combination HIV Prevention Intervention in a Hyper-Endemic Community
- (2013) Ramzi A. Alsallaq et al. PLoS One
- Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
- (2013) Stéphane Verguet et al. SEXUALLY TRANSMITTED INFECTIONS
- The marginal willingness-to-pay for attributes of a hypothetical HIV vaccine
- (2013) Michael P. Cameron et al. VACCINE
- Study designs for identifying risk compensation behavior among users of biomedical HIV prevention technologies: Balancing methodological rigor and research ethics
- (2013) Kristen Underhill SOCIAL SCIENCE & MEDICINE
- The new role of antiretrovirals in combination HIV prevention
- (2012) Ide Cremin et al. AIDS
- The Cost-effectiveness of Pre-Exposure Prophylaxis for HIV Infection in South African Women
- (2012) R. P. Walensky et al. CLINICAL INFECTIOUS DISEASES
- Use of conjoint analysis to assess HIV vaccine acceptability: feasibility of an innovation in the assessment of consumer health-care preferences
- (2012) S J Lee et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
- (2012) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050
- (2012) Reuben Granich et al. PLoS One
- Economics of antiretroviral treatment vs. circumcision for HIV prevention
- (2012) T. Barnighausen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acceptability in microbicide and PrEP trials
- (2012) Barbara S. Mensch et al. Current Opinion in HIV and AIDS
- The Potential Impact of Pre-Exposure Prophylaxis for HIV Prevention among Men Who Have Sex with Men and Transwomen in Lima, Peru: A Mathematical Modelling Study
- (2012) Gabriela B. Gomez et al. PLOS MEDICINE
- Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations
- (2011) J T Galea et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Epidemiological Impact of Tenofovir Gel on the HIV Epidemic in South Africa
- (2011) Brian G Williams et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Modeling the gender-specific impact of vaginal microbicides on HIV transmission
- (2011) Dobromir T. Dimitrov et al. JOURNAL OF THEORETICAL BIOLOGY
- Prevention of HIV-1 Infection with Early Antiretroviral Therapy
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progress and challenges to male and female condom use in South Africa
- (2011) Mags E. Beksinska et al. Sexual Health
- Expected epidemiological impact of the introduction of a partially effective HIV vaccine among men who have sex with men in Australia
- (2011) Richard T. Gray et al. VACCINE
- Optimal Uses of Antiretrovirals for Prevention in HIV-1 Serodiscordant Heterosexual Couples in South Africa: A Modelling Study
- (2011) Timothy B. Hallett et al. PLOS MEDICINE
- Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies
- (2010) David R. Friend et al. ANTIVIRAL RESEARCH
- Multipurpose prevention technologies for sexual and reproductive health: gaining momentum and promise
- (2010) Bethany Young Holt et al. CONTRACEPTION
- A systematic review and meta-analysis of quantitative interviewing tools to investigate self-reported HIV and STI associated behaviours in low- and middle-income countries
- (2010) Anna E Phillips et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial
- (2010) Sheena McCormack et al. LANCET
- Vaginal microbicides save money: a model of cost-effectiveness in South Africa and the USA
- (2010) S. Verguet et al. SEXUALLY TRANSMITTED INFECTIONS
- Hypothetical bias, choice experiments and willingness to pay
- (2010) David A. Hensher TRANSPORTATION RESEARCH PART B-METHODOLOGICAL
- Preventive HIV Vaccine Acceptability and Behavioral Risk Compensation among a Random Sample of High-Risk Adults in Los Angeles (LA VOICES)
- (2009) Peter A. Newman et al. HEALTH SERVICES RESEARCH
- Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention
- (2009) Andrew Nunn et al. Trials
- Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand
- (2009) Peter A. Newman et al. VACCINE
- SILCS diaphragm: postcoital testing of a new single-size contraceptive device
- (2008) Jill L. Schwartz et al. CONTRACEPTION
- Eliciting the demand for long-term care coverage: a discrete choice modelling analysis
- (2007) Rinaldo Brau et al. HEALTH ECONOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started